Active Immunization of Sibling Bone Marrow Transplant Donors Against Purified Myeloma Protein of the Recipient Undergoing Allogeneic Bone Marrow Transplantation
PHASE3
Both patients and marrow donors are treated on Regimen A; patients then pro...
Trial of Activated Marrow Infiltrating Lymphocytes Alone or in Conjunction With an Allogeneic Granulocyte Macrophage Colony-stimulating Factor (GM-CSF)-Based Myeloma Cellular Vaccine in the Autologous Transplant Setting in Multiple Myeloma
PHASE2
Patient Population: Patients with active myeloma (Stage II/III) that have c...
Status
Completed
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy
PHASE1
RATIONALE: Vaccines may help the body build an effective immune response to...
Status
Completed
Location
Penn State Hershey Cancer Institute at Milton S. Hershey Medical Center
Trial of ID-Specific Donor Vaccinated Lymphocyte Infusion for Patients With Myeloma Relapsing or Failing to Achieve a Complete Remission After an Allogenic Transplant
PHASE2
The goal of this clinical research study is to learn if vaccinating a donor...